11Feb/14

Children's Medical Center to Host 23rd Annual 'Be The Match' Donor Registry … – The Herald | HeraldOnline.com (press release)

Children’s Medical Center to Host 23rd Annual ‘Be The Match’ Donor Registry
The Herald | HeraldOnline.com (press release)
Another development has been the use of blood and marrow stem cell transplant to treat and even cure children with severe sickle cell disease, one of the most common serious genetic disorders in the world. Sickle cell disease is most commonly found 

and more »

11Feb/14

Children's Medical Center to Host 23 rd Annual 'Be The Match' Donor Registry … – Business Wire (press release)

Children’s Medical Center to Host 23 rd Annual ‘Be The Match’ Donor Registry
Business Wire (press release)
Another development has been the use of blood and marrow stem cell transplant to treat and even cure children with severe sickle cell disease, one of the most common serious genetic disorders in the world. Sickle cell disease is most commonly found 

and more »

11Feb/14

Resilience in parents of children undergoing stem cell transplant – Medical Xpress

Resilience in parents of children undergoing stem cell transplant
Medical Xpress
However, a study recently published in the journal Biology of Blood and Marrow Transplantation shows that in the case of a child’s stem cell transplant, parents feel increased distress at the time of the procedure, but eventually recover to normal
Children’s Medical Center to Host 23rd Annual ‘Be The Match’ Donor Registry The Herald | HeraldOnline.com (press release)

all 4 news articles »

11Feb/14

FDA Investigating Heart Failure Risk Linked To Onglyza – Forbes


Drug Discovery & Development

FDA Investigating Heart Failure Risk Linked To Onglyza
Forbes
ureThe FDA said today that it was conducting an investigation of a possible increased risk for heart failure associated with the diabetes drug saxagliptin. Saxagliptin is marketed by AstraZeneca AstraZeneca as Onglyza and Kombiglyze XR. (AstraZeneca 
FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure RiskU.S. News & World Report
FDA to probe saxagliptin’s heart failure riskFamily Practice News Digital Network
FDA Investigating Heart Failure Risks with SaxagliptinDrug Discovery & Development
Healio
all 27 news articles »